**To the Editor:** *Mycobacterium ulcerans* is an emerging human pathogen responsible for Buruli ulcer, a necrotizing skin disease most commonly found in West Africa, but outbreaks have also been reported in the Americas, Australia, and Asia ([@R1]). Environmental sources of infection and mode of transmission are not completely known. *M. ulcerans* grows slowly at 32°C, requiring 6--8 weeks for colonies to be visible in primary culture. Differentiation from *M. marinum*, which also causes skin infections, is important, since *M. marinum* can usually be treated with antimicrobial agents, whereas *M. ulcerans* most often does not respond favorably to drug therapy, and treatment is usually by surgical excision ([@R2]). *M. shinshuense*, initially isolated from a child in Japan, is phenotypically and genetically related but biochemically distinct from *M. ulcerans* ([@R3]).

In the last decade, several DNA-based techniques for mycobacterial identification have been developed. Rapid molecular detection and differentiation of organisms that cause skin infections directly from tissue or exudates could be of great value for early treatment. Some techniques, especially those that include nucleic acid amplification, could be used directly on clinical samples. The accepted standard for molecular identification of mycobacteria is sequencing analysis of 2 hypervariable regions identified in 16S rRNA gene. *M. marinum* and *M. ulcerans* share identical 5´-16S rDNA and 16S-23S rRNA gene spacer sequences ([@R4]). Polymerase chain reaction (PCR)-dependent methods are based on the 16S rRNA gene ([@R5]), the *hsp65* gene ([@R6]) or the insertion sequence IS*2404* ([@R7]). Recently, a novel category of variable number tandem repeats that could distinguish *M. marinum* and *M. ulcerans* genotypes has been described ([@R8]).

Polymorphisms in the 3´-16S rDNA region discriminate *M. ulcerans* from *M. marinum* and *M. shinshuense* ([@R5]). These polymorphisms also allow the separation of *M. ulcerans* into 3 subgroups according to geographic origin and variable phenotypic differences. IS*2404* discriminates *M. ulcerans* from *M. marinum* ([@R7]). It has been used in restriction fragment length polymorphism analysis applied to a comparable number of *M. ulcerans* and *M. marinum* strains, confirming that this sequence is present in high copy numbers in *M. ulcerans* but absent in *M. marinum*. Nevertheless, an unusual mycobacterium was recently isolated that is closely related to *M. marinum* by phenotypic tests, lipid pattern, and partial 16S rDNA sequencing but presents low copy numbers of this element ([@R9]).

PCR-restriction enzyme analysis (PRA) of a 441-bp fragment of the *hsp65* gene is a rapid, easy, and inexpensive method for identifying mycobacteria ([@R10]). Devallois et al. ([@R6]) described the PRA-*hsp65* pattern of 1 *M. ulcerans* strain ATCC 33728 that originated in Japan. This isolate was considered a new species that resembled *M. ulcerans* and was named *M. shinshuense* ([@R3]).

We report here the usefulness of PRA-*hsp65* to differentiate *M. ulcerans* strains from different geographic areas. Since Buruli ulcer cases have been reported on 5 continents, we studied 33 *M. ulcerans* strains that originated from Africa (Benin, Zaire, Ghana, Congo, Angola, Côte d\'Ivoire, Togo), Asia (China, Malaysia), Australia (Papua New Guinea, Australia), the Caribbean (Mexico, Surinam, French Guiana), 1 *M. shinshuense* from Japan, 1 *M. marinum* isolate and 1 IS*2404*-positive *M. marinum* isolate from France ([@R9]). All strains were identified at the Institute of Tropical Medicine, the World Health Organization Collaborating Centre for the Diagnosis and Surveillance of *Mycobacterium ulceran*s Infection by IS*2404* PCR and biochemical tests ([Table](#T1){ref-type="table"}).

###### Origin of strains used in this study\*

  ITM no.   Species identification     Geographic origin   Source   Providers†         PRA-*hsp65*
  --------- -------------------------- ------------------- -------- ------------------ -------------
  960657    *Mycobacterium ulcerans*   Angola              Human    ITM                I
  960658    *M. ulcerans*              Angola              Human    ITM                I
  5142      *M. ulcerans*              Australia           Human    ATCC 19423         I
  5147      *M. ulcerans*              Australia           Human    JS                 I
  8849      *M. ulcerans*              Australia           Human    DD 8471/69         I
  9540      *M. ulcerans*              Australia           Human    DD 11098           I
  9550      *M. ulcerans*              Australia           Human    DD 17679           I
  940339    *M. ulcerans*              Australia           Human    ITM                I
  1441      *M. ulcerans*              Benin               Insect   ITM                I
  9146      *M. ulcerans*              Benin               Human    ITM                I
  940512    *M. ulcerans*              Benin               Human    ITM                I
  940886    *M. ulcerans*              Benin               Human    ITM                I
  970010    *M. ulcerans*              Benin               Human    ITM                I
  970104    *M. ulcerans*              Benin               Human    ITM                I
  970111    *M. ulcerans*              Benin               Human    ITM                I
  980912    *M. ulcerans*              China               Human    W.R Faber          II
  5150      *M. ulcerans*              D.R.Congo           Human    ITM                I
  5151      *M. ulcerans*              D.R.Congo           Human    ITM                I
  5155      *M. ulcerans*              D.R.Congo           Human    ITM                I
  7922      *M. ulcerans*              French Guiana       Human    IPP 1410900        I
  970321    *M. ulcerans*              Ghana               Human    ITM                I
  970359    *M. ulcerans*              Ghana               Human    ITM                I
  970483    *M. ulcerans*              Ghana               Human    ITM                I
  940511    *M. ulcerans*              Côte d\'Ivoire      Human    ITM                I
  940662    *M. ulcerans*              Côte d\'Ivoire      Human    ITM                I
  940815    *M. ulcerans*              Côte d\'Ivoire      Human    ITM                I
  941328    *M. ulcerans*              Malaysia            Human    K. Jackson 18651   I
  5114      *M. ulcerans*              Mexico              Human    PL                 I
  5143      *M. ulcerans*              Mexico              Human    ITM                I
  9537      *M. ulcerans*              Papua New Guinea    Human    DD 11878           I
  941331    *M. ulcerans*              Papua New Guinea    Human    ITM                I
  842       *M. ulcerans*              Surinam             Human    VK 701357          I
  970680    *M. ulcerans*              Togo                Human    ITM                I
  8756      *M. shinshuense*           Japan               Human    ATCC 33728         II
  1027      *M. marinum*               France              Human    VV IPP 99363       I
  1026      *M. marinum*               France              Human    VV IPP2000372      I

\*PCR restriction enzyme analysis--*hsp65* patterns: I \[*Bst*EII and *Hae*III (bp) of 235/210/0 and 145/105/80\] and II \[*Bst*EII and *Hae*III (bp) of 235/210/0 and 190/105/80\]. †ATCC, American Type Culture Collection; ITM, Institute of Tropical Medicine, Antwerp, Belgium; IPP, Institut Pasteur, Paris, France; VK, Academic Medical Center, Amsterdam, the Netherlands; JS, J Standford, School of Pathology, London, United Kingdom; DD, D Dawson, Laboratory of Microbiology and Pathology, Queensland Health, Australia; PL, P Lavalle, Centro Dermatologico Pascua, Mexico City, Mexico; VV, V Vincent, IPP, Paris, France.

DNA extracted from cultures by 3 freeze-boiling cycles was used for amplification, according to the protocol described by Leao et al. ([@R10]). Gel images were analyzed by using GelCompar II v. 2.5 (AppliedMaths, Sint-Martens-Latem, Belgium). Two distinct *M. ulcerans* PRA-*hsp65* patterns were identified. Of 36 strains, 34 had a PRA-*hsp65* pattern indistinguishable from that of *M. marinum* \[*Bst*EII and *Hae*III (bp) of 235/210/0 and 145/105/80\] at the Swiss PRAsite (<http://app.chuv.ch/prasite/index.html>). Two strains, 1 each from Japan and China, showed a different pattern \[*Bst*EII and *Hae*III (bp) of 235/210/0 and 190/105/80\], that described by Devallois et al. ([@R6]).

We have shown that PRA-*hsp65* analysis performed on several *M. ulcerans* strains from different geographic areas produced different patterns. In fact, the unique PRA-*hsp65* profile of the *M. ulcerans* strain previously published ([@R6]) was the most rarely found pattern among the profiles found in this study. This work helps to clarify the PRA-*hsp65* patterns of *M. ulcerans* found in different countries. Because the epidemiology of Buruli ulcer is poorly understood, new molecular tools are still needed to differentiate *M. ulcerans* from different geographic settings, mainly in Africa, where the disease is more prevalent. The PRA-*hsp65* method represents a rapid, easy, and inexpensive technique to differentiate *M. shinshuense* from *M. ulcerans* and *M. marinum*.
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